Home LiteratureArticle Details
PMID: 11379545 Published · ppublish English Comment Editorial Review

A potential new therapy for sepsis: learning from experience.

Critical care medicine ·Vol. 29 ·No. 3 ·2001-03-00 ·Pages 690-1

Burnham E, Moss M

Abstract

暂无摘要

MeSH Terms
Animals Critical Care/methods,trends Disease Models, Animal Immunosuppressive Agents/immunology,therapeutic use Interleukin-1/antagonists & inhibitors,immunology Pyrazoles/immunology,therapeutic use Pyridines/immunology,therapeutic use Rats Research Design Sepsis/drug therapy,immunology Tumor Necrosis Factor-alpha/antagonists & inhibitors,immunology
Chemicals
FR 167653 Immunosuppressive Agents Interleukin-1 Pyrazoles Pyridines Tumor Necrosis Factor-alpha
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Burnham E
Moss M
Article Info
Journal
Critical care medicine
Abbr.
Crit Care Med
ISSN
0090-3493
DOI
10.1097/00003246-200103000-00052
Published
2001-03-00
Pages
690-1
Language
English
Region
United States
NLM ID
0355501
Subset
IM
Corrections
CommentOn
PMID: 11373433
External Links
PubMed source DOI: 10.1097/00003246-200103000-00052 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2